Citation Impact
Citing Papers
Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
2015 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
2011
Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
2014 Standout
Contributing Knowledge to Electronic Knowledge Repositories: An Empirical Investigation1
2005 Standout
Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK
2019
Ferroptosis: past, present and future
2020 Standout
Mechanisms of ferroptosis
2016
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
2016
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Axon Guidance Molecules in Vascular Patterning
2010
Hepatocellular carcinoma
2018 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses
2013
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
2014
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
2018
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Medical management of brain tumors and the sequelae of treatment
2014
Origins and functions of liver myofibroblasts
2013
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
2015
The molecular machinery of regulated cell death
2019 Standout
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
2014
γ-Glutamylcysteine synthetase (γ-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells
2018
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
2017
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
2014
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
2014
Understanding the mechanisms and treatment options in cancer cachexia
2012
Cancer-associated cachexia
2018 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer
2016
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
2018
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells
2017
Targeting apoptosis in cancer therapy
2020 Standout
Bladder cancer
2016 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Sarcopenia
2019 Standout
Oxidative Stress in Cancer
2020 Standout
Ferroptosis: process and function
2016 Standout
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Host-directed therapies for bacterial and viral infections
2017
The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications
2011
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
2011
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
The development of the concept of ferroptosis
2018
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
2013
The Pathobiology of Vascular Dementia
2013 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
ESPEN expert group recommendations for action against cancer-related malnutrition
2017
Wiring the Vascular Network with Neural Cues: A CNS Perspective
2015
“Head-to-Side-Chain” Cyclodepsipeptides of Marine Origin
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Transketolase counteracts oxidative stress to drive cancer development
2016
Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes
2009
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
2013
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
2013
Bladder Cancer
2020 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
The Hallmarks of Ferroptosis
2018
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
On Organizational Becoming: Rethinking Organizational Change
2002 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Guidance of Vascular Development
2009
Organocatalytic α‐Addition of Isocyanides to Aldehydes
2014 StandoutNobel
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
2011
Cracking the code of change.
2001
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Works of Stanislas Ropert being referenced
Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
2012
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
2012
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities
2005
Treatment of bevacizumab-induced hypertension by amlodipine
2010
Reactivation of tuberculosis during temsirolimus therapy
2010
Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience
2009
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib
2012
Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2
2012
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
2013
Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
2010
Posterior reversible encephalopathy syndrome induced by anti-VEGF agents
2011
Emerging therapeutic options for breast cancer chemotherapy during pregnancy
2007
Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
2011
An Observational Study of Bevacizumab-Induced Hypertension as a Clinical Biomarker of Antitumor Activity
2011
Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis
2012
Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B
2008